UKIZUK Innovation ZonesA TAIU initiative

Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Side by side

DimensionLeeds & West YorkshireYorkshire and the HumberCornwall & PlymouthSouth WestCambridgeEast of England
Sectors

Life Sciences, Digital Technologies, Financial Technology

Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries

Space, Clean Energy, Robotics & Autonomous Systems

Supporting: Advanced Materials, AgriTech & FoodTech, Digital Technologies

Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence

Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies

Research
  • University of Leeds
  • University of Plymouth
  • Plymouth Marine Laboratory
  • University of Cambridge
  • Wellcome Sanger Institute
  • MRC Laboratory of Molecular Biology
Companies
  • Leeds health data and digital health cluster

Not recorded on the map.

  • Cambridge semiconductor and processor IP cluster
Infrastructure

Not recorded on the map.

Health data infrastructure, teaching hospitals and university research facilities.

  • Space and Earth observation capability, Cornwall

Aerodrome and space capability, marine research and test facilities and naval infrastructure.

  • Babraham Research Campus
  • Cambridge Science Park

University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.

Capital

Financial services depth locally, but early-stage health technology capital remains limited.

Public programmes and a small local investor base; almost all growth capital is external.

Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.

Government programmes

No place-based designation recorded.

No place-based designation recorded.

No place-based designation recorded.

What existsNational health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength.Space launch and Earth observation capability, marine autonomy and ocean research, and a distinctive combination of coastline, test space and specialist facilities.Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.
What's missing · UKIZ interpretationA clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects.Company density and connectivity. Excellent facilities sit a long way from capital, customers and complementary suppliers, and skilled people are hard to retain.Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.
What could connect · UKIZ interpretationLeeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region.Launch and Earth observation connected to Glasgow satellite manufacture and Harwell applications, and marine autonomy connected to Solent defence and offshore energy demand.Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.
UKIZ relevanceHealth data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing.The proposed Cornwall & Devon mission treats the sea and the satellite economy as one system rather than two separate sectors.Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.
Last verified15 August 202615 August 202615 August 2026

Proposed by UKIZ · independent · not a government designation